Could the Microbiota Be a Predictive Factor for the Clinical Response to Probiotic Supplementation in IBS-D? A Cohort Study.

Justine MarchixLucille QuénéhervéPhilippe BordronPhilippe AubertTony DurandThibauld OullierClaude BlondeauSamira Ait AbdellahStanislas Bruley des VarannesSamuel ChaffronEmmanuel CoronMichel Neunlist

Published in: Microorganisms (2023)

The multistrain probiotic improved the symptoms of IBS-D patients and induced distinct effects on the gut microbiota according to the patient's clinical response and initial microbiota composition. Our study further supports the need to develop individualised probiotic-based approaches regarding IBS.

Keyphrases

end stage renal disease
irritable bowel syndrome
bacillus subtilis
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
case report